http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2369264-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate | 1977-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1978-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-2369264-A1 |
| titleOfInvention | ISOPROPYL-D-1,4-DIHYDRO-2,6-DIMETHYL-4- (3-NITROPHENYL) -3,5-PYRIDINE-DICARBOXYLATE |
| abstract | The present invention relates, as a new compound, to isopropyl and 2-propoxyethyl 1,4-dihydro-2,6-dimethyl-4- (3-nitrophenyl) -3,5-pyridine-carboxylate. This compound is obtained by a process, one of the variants of which consists in reacting isopropyl 3'-nitrobenzylidene acetylacetate with 2-propoxyethyl beta-aminocrotonate. The compound of the invention can be used as a medicament. It produces intense and long-lasting vasodilation when administered enterally and parenterally and therefore can be used for therapy and prophylaxis of peripheral circulatory disorders. |
| priorityDate | 1976-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.